Literature DB >> 846518

Vinblastine and inappropriate ADH secretion.

S J Ginsberg, R L Comis, A V Fitzpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 846518     DOI： 10.1056/nejm197704212961615

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Life-threatening hyponatremia caused by vinblastine.

Authors:  G Zavagli; G Ricci; G Tataranni; G Mapelli; V Abbasciano
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

Review 2.  Hyponatremia related to medical anticancer treatment.

Authors:  T Berghmans
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

3.  Syndrome of inappropriate ADH secretion secondary to vinblastine.

Authors:  R A Stahel; O Oelz
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors.

Authors:  C Focan; R Olivier; S Le Hung; R Bays; J J Claessens; H Debruyne
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.